Quarterly Results • Search Archive
Krebs Biochemicals and Industries Limited
Results, Financials & Updates
Follow Krebs Biochemicals and Industries Limited results and financial updates in one company page: latest revenue or income, profit, margins, quarter comparisons, what changed and detailed Nivata Results deep dives.
2 published deep dives
2 quarters 1 sector
Company Overview
Krebs Biochemicals and Industries Limited: latest results and financials
About the business in Nivata's latest coverage
Krebs Biochemicals and Industries Limited manufactures biochemicals, active pharmaceutical ingredients (APIs), and intermediates through fermentation and chemical synthesis processes. The company operates its principal manufacturing infrastructure out of Andhra Pradesh. The operational model relies heavily on active manufacturing output from its core plant facilities to generate commercial scale revenue. Sales are primarily derived from pharmaceutical and biochemical product supply lines to domestic and international clients.
Quarter History
Krebs Biochemicals and Industries reported trend
Each row comes from the corresponding Nivata Results brief. Reporting scope can differ between quarters; open the quarter for full context.
Quarter history
Krebs Biochemicals and Industries Limited Results & Financials
Latest Nivata coverage: Q2 FY27 · revenue ₹5.79 Cr · PAT ₹-5.40 Cr.
MainboardQ2 FY27
Krebs Biochemicals and Industries Limited
HealthcareNSE: KREBSBIO · Standalone
Revenue from operations · current quarter₹5.79 CrReported Q2 FY27 Profit after tax · current quarter₹-5.40 CrReported Q2 FY27
Read the results deep dive ↗
MainboardQ1 FY27
Krebs Biochemicals and Industries Limited
HealthcareNSE: KREBSBIO · Standalone
Revenue from operations · current quarter₹6.98 CrReported Q1 FY27 Profit after tax · current quarter₹-2.48 CrReported Q1 FY27
Read the results deep dive ↗